StockData
RVRCOTCPharmaceutical PreparationsFiscal year ends December 31

Revium Rx.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.43+0.00 (0.00%)

Close on Oct 16, 2026

Market cap
$86.84M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Revium Rx. has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Revium Rx. filed with the SEC